Lajoie Laurie (Laurie Lajoie)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Particulate Matter

Toxoplasma Gondii

Top Venues

Journal for immunotherapy of cancer

Antibodies (Basel, Switzerland)

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Pénélope Desroys du Roure, Lajoie Laurie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou, Véronique Garambois, Lucie Rubio, Timothée David, Loïs Coënon, Florence Boissière, Marie-Christine Chateau, Giang Ngo, Marta Jarlier, Martín Villalba, Pierre Martineau, Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Laurent Gros, Emmanuelle Liaudet-Coopman
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for immunotherapy of cancer 12 (1) (2024)
Muna Aljieli, Clément Rivière, Louis Lantier, Nathalie Moiré, Zineb Lakhrif, Anne-France Boussemart, Thomas Cnudde, Lajoie Laurie, Nicolas Aubrey, Elhadi M Ahmed, Isabelle Dimier-Poisson, Anne Di-Tommaso, Marie-Noëlle Mévélec
Specific Cell Targeting by Toxoplasma gondii Displaying Functional Single-Chain Variable Fragment as a Novel Strategy; A Proof of Principle. Cells 13 (11) (2024)
Pénélope Desroys du Roure, Lajoie Laurie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou, Véronique Garambois, Lucie Rubio, Timothée David, Loïs Coënon, Florence Boissière, Marie-Christine Chateau, Giang Ngo, Marta Jarlier, Martín Villalba, Pierre Martineau, Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Laurent Gros, Emmanuelle Liaudet-Coopman
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for immunotherapy of cancer 12 (1) (2024)
Pénélope Desroys du Roure, Lajoie Laurie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou, Véronique Garambois, Lucie Rubio, Timothée David, Loïs Coënon, Florence Boissière, Marie-Christine Chateau, Giang Ngo, Marta Jarlier, Martín Villalba, Pierre Martineau, Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Laurent Gros, Emmanuelle Liaudet-Coopman
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for immunotherapy of cancer 12 (1) (2024)
Pénélope Desroys du Roure, Lajoie Laurie, Aude Mallavialle, Lindsay B Alcaraz, Hanane Mansouri, Lise Fenou, Véronique Garambois, Lucie Rubio, Timothée David, Loïs Coënon, Florence Boissière, Marie-Christine Chateau, Giang Ngo, Marta Jarlier, Martín Villalba, Pierre Martineau, Valérie Laurent-Matha, Pascal Roger, Séverine Guiu, Thierry Chardès, Laurent Gros, Emmanuelle Liaudet-Coopman
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for immunotherapy of cancer 12 (1) (2024)
Muna Aljieli, Clément Rivière, Louis Lantier, Nathalie Moiré, Zineb Lakhrif, Anne-France Boussemart, Thomas Cnudde, Lajoie Laurie, Nicolas Aubrey, Elhadi M Ahmed, Isabelle Dimier-Poisson, Anne Di-Tommaso, Marie-Noëlle Mévélec
Specific Cell Targeting by Toxoplasma gondii Displaying Functional Single-Chain Variable Fragment as a Novel Strategy; A Proof of Principle. Cells 13 (11) (2024)
Olivier Reynard, Claudia Gonzalez, Claire Dumont, Mathieu Iampietro, Marion Ferren, Sandrine Le Guellec, Lajoie Laurie, Cyrille Mathieu, Gabrielle Carpentier, Georges Roseau, Francesca T Bovier, Yun Zhu, Deborah Le Pennec, Jérome Montharu, Amin Addetia, Alexander L Greninger, Christopher A Alabi, Elise Brisebard, Anne Moscona, Laurent Vecellio, Matteo Porotto, Branka Horvat
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection. Nature communications 13 (1) (2022)
Nicolas Aubrey, Valérie Gouilleux-Gruart, Christine Dhommée, Julie Mariot, Fanny Boursin, Nicolas Albrecht, Cécile Bergua, Cécile Croix, Mäelle Gilotin, Eloi Haudebourg, Catherine Horiot, Laetitia Matthias, Caroline Mouline, Lajoie Laurie, Audrey Munos, Gilles Ferry, Marie-Claude Viaud-Massuard, Gilles Thibault, Florence Velge-Roussel
Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality. Antibodies (Basel, Switzerland) 11 (3) (2022)
Olivier Reynard, Claudia Gonzalez, Claire Dumont, Mathieu Iampietro, Marion Ferren, Sandrine Le Guellec, Lajoie Laurie, Cyrille Mathieu, Gabrielle Carpentier, Georges Roseau, Francesca T Bovier, Yun Zhu, Deborah Le Pennec, Jérome Montharu, Amin Addetia, Alexander L Greninger, Christopher A Alabi, Anne Moscona, Laurent Vecellio, Matteo Porotto, Branka Horvat
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection. Research square (2022)